NeuroBo Pharmaceuticals, Inc. (NRBO) reported a significant increase in its second-quarter loss compared to the previous year, failing to meet Wall Street expectations.
The company's net loss for the quarter was $10.05 million, or $1.85 per share, compared to a loss of $0.73 million, or $0.15 per share, in the same quarter last year.
Analysts, based on data from Thomson Reuters, had anticipated a loss of $1.12 per share on average. It’s important to note that these projections typically exclude special items.
Key financial highlights for NeuroBo Pharmaceuticals, Inc. (GAAP):
- Quarterly Earnings (Q2): Loss of $10.05 million vs. loss of $0.73 million last year.
- Earnings Per Share (EPS, Q2): Loss of $1.85 vs. loss of $0.15 last year.
